OR2B3
geneOn this page
Also known as OR6-4
Summary
OR2B3 (olfactory receptor family 2 subfamily B member 3, HGNC:8238) is a protein-coding gene on chromosome 6p22.1, encoding Putative olfactory receptor 2B3 (O76000). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 442184 — RefSeq curated summary.
At a glance
- GWAS associations: 24
- Clinical variants (ClinVar): 37 total
- MANE Select transcript:
NM_001005226
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8238 |
| Approved symbol | OR2B3 |
| Name | olfactory receptor family 2 subfamily B member 3 |
| Location | 6p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OR6-4 |
| Ensembl gene | ENSG00000204703 |
| Ensembl biotype | protein_coding |
| Entrez | 442184 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000377173
RefSeq mRNA: 1 — MANE Select: NM_001005226
NM_001005226
CCDS: CCDS34358
Canonical transcript exons
ENST00000377173 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001617449 | 29086208 | 29087313 |
Expression profiles
Bgee: expression breadth tissue_specific, 2 present calls, max score 80.73.
Top tissues by expression
128 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.73 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 39.20 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| liver | UBERON:0002107 | 28.61 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| urinary bladder | UBERON:0001255 | 27.93 | gold quality |
| adrenal tissue | UBERON:0018303 | 27.78 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| calcaneal tendon | UBERON:0003701 | 27.41 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 27.22 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| leukocyte | CL:0000738 | 26.63 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| monocyte | CL:0000576 | 26.53 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.09 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2D2 (ENSG00000166368), OR2B2 (ENSG00000168131), OR2C1 (ENSG00000168158), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR10A2 (ENSG00000170790), OR13H1 (ENSG00000171054), OR2K2 (ENSG00000171133), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10H5 (ENSG00000172519), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2T33 (ENSG00000177212), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T29 (ENSG00000182783), OR2T34 (ENSG00000183310)
Protein
Protein identifiers
Putative olfactory receptor 2B3 — O76000 (reviewed: O76000)
Alternative names: Hs6M1-1, Olfactory receptor OR6-14
All UniProt accessions (2): O76000, A0A126GV76
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001005226* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (18 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O76000-F1 | 85.90 | 0.45 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 17 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, WP_GPCRS_CLASS_A_RHODOPSINLIKE, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
232 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR2B3 | SLC35F4 | A4IF30 | 665 |
| OR2B3 | TMEM196 | Q5HYL7 | 641 |
| OR2B3 | TSR3 | Q9UJK0 | 583 |
| OR2B3 | KLHL25 | Q9H0H3 | 580 |
| OR2B3 | ZNF311 | Q5JNZ3 | 580 |
| OR2B3 | STARD3NL | O95772 | 540 |
| OR2B3 | ANAPC13 | Q9BS18 | 507 |
| OR2B3 | CDC42SE2 | Q9NRR3 | 507 |
| OR2B3 | BUD13 | Q9BRD0 | 477 |
| OR2B3 | TRIM10 | Q9UDY6 | 435 |
| OR2B3 | RTP1 | P59025 | 417 |
| OR2B3 | GALR1 | P47211 | 399 |
| OR2B3 | TRIM40 | Q6P9F5 | 393 |
| OR2B3 | MUCL3 | Q3MIW9 | 370 |
| OR2B3 | TAS2R60 | P59551 | 333 |
IntAct
0 interactions, top by confidence:
BioGRID (2): CFL1 (Cross-Linking-MS (XL-MS)), OR2B3 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A6NCV1, A6NF89, A6NJZ3, A6NL08, A6NM76, O76000, O95007, O95221, P0C626, P0C629, P30955, P37070, P70526, Q15617, Q15620, Q60882, Q60893, Q60895, Q6IEU7, Q8N0Y5, Q8N162, Q8NGE1, Q8NGG4, Q8NGG8, Q8NGH3, Q8NGL1, Q8NGP8, Q8NGP9, Q8NGR5, Q8NGR8, Q8NGS4, Q8NGT1, Q8NGX3, Q8NH01, Q8VEW5, Q8VF66, Q8VF76, Q8VFD0, Q8VFD3, Q8VFK2
Diamond homologs: A3KFT3, A4D2G3, A6NH00, A6NL26, A6NM03, O43869, O76000, O76001, O76002, O95006, O95221, O95371, O95918, P0C7N1, P0C7T2, P23274, P23275, P34984, P59922, Q13606, Q13607, Q5TZ20, Q60880, Q60890, Q6IEZ7, Q6IF00, Q8N127, Q8N349, Q8N628, Q8NG75, Q8NG76, Q8NG77, Q8NG80, Q8NG81, Q8NG83, Q8NG84, Q8NG85, Q8NG97, Q8NGC0, Q8NGE5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
37 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 28 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
263 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:29086492:C:CT | acceptor_gain | 0.6400 |
| 6:29086618:C:CC | acceptor_gain | 0.6300 |
| 6:29086658:AG:A | donor_gain | 0.6300 |
| 6:29087257:A:AC | donor_gain | 0.6100 |
| 6:29087258:C:CC | donor_gain | 0.6100 |
| 6:29087193:T:C | donor_gain | 0.5300 |
| 6:29086376:GCTGT:G | acceptor_gain | 0.5100 |
| 6:29086414:CA:C | acceptor_gain | 0.5100 |
| 6:29086446:T:C | acceptor_gain | 0.5100 |
| 6:29086731:T:TA | donor_gain | 0.5100 |
| 6:29086483:TGG:T | acceptor_gain | 0.5000 |
| 6:29086493:A:C | acceptor_gain | 0.5000 |
| 6:29086659:G:C | donor_gain | 0.5000 |
| 6:29087262:T:C | donor_gain | 0.5000 |
| 6:29086617:A:AC | acceptor_gain | 0.4800 |
| 6:29086492:C:T | acceptor_gain | 0.4500 |
| 6:29086594:CA:C | acceptor_gain | 0.4500 |
| 6:29087261:A:AC | donor_gain | 0.4500 |
| 6:29086613:TGTCA:T | acceptor_gain | 0.4400 |
| 6:29086616:CA:C | acceptor_gain | 0.4400 |
| 6:29086415:A:C | acceptor_gain | 0.4300 |
| 6:29086456:A:C | acceptor_gain | 0.4300 |
| 6:29086481:AATGG:A | acceptor_gain | 0.4300 |
| 6:29086575:A:AC | donor_gain | 0.4300 |
| 6:29086576:C:CC | donor_gain | 0.4300 |
| 6:29086576:CTG:C | donor_gain | 0.4300 |
| 6:29086707:AC:A | donor_gain | 0.4300 |
| 6:29086708:CC:C | donor_gain | 0.4300 |
| 6:29087055:T:TC | acceptor_gain | 0.4300 |
| 6:29086316:A:AC | donor_gain | 0.4200 |
AlphaMissense
2067 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:29087213:A:C | F12L | 0.900 |
| 6:29087213:A:T | F12L | 0.900 |
| 6:29087215:A:G | F12L | 0.900 |
| 6:29086496:A:C | F251L | 0.791 |
| 6:29086496:A:T | F251L | 0.791 |
| 6:29086498:A:G | F251L | 0.791 |
| 6:29087198:G:C | F17L | 0.790 |
| 6:29087198:G:T | F17L | 0.790 |
| 6:29087200:A:G | F17L | 0.790 |
| 6:29086937:G:C | F104L | 0.753 |
| 6:29086937:G:T | F104L | 0.753 |
| 6:29086939:A:G | F104L | 0.753 |
| 6:29087066:G:C | F61L | 0.718 |
| 6:29087066:G:T | F61L | 0.718 |
| 6:29087068:A:G | F61L | 0.718 |
| 6:29086535:A:C | F238L | 0.688 |
| 6:29086535:A:T | F238L | 0.688 |
| 6:29086537:A:G | F238L | 0.688 |
| 6:29087063:A:C | F62L | 0.687 |
| 6:29087063:A:T | F62L | 0.687 |
| 6:29087065:A:G | F62L | 0.687 |
| 6:29086718:A:C | F177L | 0.684 |
| 6:29086718:A:T | F177L | 0.684 |
| 6:29086720:A:G | F177L | 0.684 |
| 6:29086418:G:C | F277L | 0.678 |
| 6:29086418:G:T | F277L | 0.678 |
| 6:29086420:A:G | F277L | 0.678 |
| 6:29086376:G:C | S291R | 0.676 |
| 6:29086376:G:T | S291R | 0.676 |
| 6:29086378:T:G | S291R | 0.676 |
dbSNP variants (sampled 300 via entrez): RS1001484535 (6:29088050 A>T), RS1001808171 (6:29089122 G>A), RS1002082419 (6:29086580 T>G), RS1002516844 (6:29087052 A>G), RS1003991701 (6:29085703 T>C), RS1004068255 (6:29086115 T>C), RS1005877263 (6:29086407 A>G,T), RS1006148822 (6:29086527 C>T), RS1007550713 (6:29088094 T>C), RS1007562035 (6:29088400 T>C), RS1009728927 (6:29088322 G>C,T), RS1012130591 (6:29085736 A>G), RS1013838472 (6:29087328 G>A), RS1013858773 (6:29087549 T>G), RS1014805981 (6:29088615 T>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
24 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002194_1 | Social communication problems | 3.000000e-07 |
| GCST003518_59 | Daytime sleep phenotypes | 3.000000e-06 |
| GCST004521_112 | Autism spectrum disorder or schizophrenia | 3.000000e-26 |
| GCST004521_212 | Autism spectrum disorder or schizophrenia | 5.000000e-14 |
| GCST004521_43 | Autism spectrum disorder or schizophrenia | 2.000000e-27 |
| GCST004521_56 | Autism spectrum disorder or schizophrenia | 1.000000e-22 |
| GCST004521_58 | Autism spectrum disorder or schizophrenia | 1.000000e-17 |
| GCST004521_7 | Autism spectrum disorder or schizophrenia | 2.000000e-15 |
| GCST004521_73 | Autism spectrum disorder or schizophrenia | 8.000000e-11 |
| GCST004521_84 | Autism spectrum disorder or schizophrenia | 1.000000e-12 |
| GCST004521_91 | Autism spectrum disorder or schizophrenia | 1.000000e-11 |
| GCST004866_25 | Alopecia areata | 9.000000e-07 |
| GCST005541_6 | Sarcoidosis (Lofgren’s syndrome vs non-Lofgren’s syndrome) | 7.000000e-19 |
| GCST006575_11 | Takayasu arteritis | 1.000000e-06 |
| GCST008916_89 | Asthma | 2.000000e-10 |
| GCST008921_4 | Asthma and major depressive disorder | 2.000000e-11 |
| GCST010142_16 | Fish- and plant-related diet | 2.000000e-10 |
| GCST010142_19 | Fish- and plant-related diet | 4.000000e-10 |
| GCST010142_34 | Fish- and plant-related diet | 7.000000e-09 |
| GCST010142_35 | Fish- and plant-related diet | 8.000000e-09 |
| GCST010142_42 | Fish- and plant-related diet | 1.000000e-08 |
| GCST010142_7 | Fish- and plant-related diet | 3.000000e-12 |
| GCST010702_75 | Subcortical volume (MOSTest) | 3.000000e-11 |
| GCST010703_272 | Brain morphology (MOSTest) | 7.000000e-16 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005427 | social communication impairment |
| EFO:0007828 | daytime rest measurement |
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium | decreases expression, increases abundance | 1 |
| Sodium Dodecyl Sulfate | affects response to substance | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): sarcoidosis